Amarantus Bioscience Financials
| AMBS Stock | USD 0.0001 0.00 0.00% |
Amarantus |
Understanding current and past Amarantus Bioscience Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amarantus Bioscience's financial statements are interrelated, with each one affecting the others. For example, an increase in Amarantus Bioscience's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Amarantus Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amarantus Bioscience Holdings. Check Amarantus Bioscience's Beneish M Score to see the likelihood of Amarantus Bioscience's management manipulating its earnings.
Amarantus Bioscience Stock Summary
Amarantus Bioscience competes with Mesabi Trust, Nutanix, Morningstar Unconstrained, Thrivent High, and Via Renewables. Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. Amarantus Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US02300U2050 |
| Business Address | 45 Wall Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.amarantus.com |
| Phone | 650 862 5391 |
| Currency | USD - US Dollar |
Amarantus Bioscience Key Financial Ratios
There are many critical financial ratios that Amarantus Bioscience's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Amarantus Bioscience reports annually and quarterly.Amarantus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amarantus Bioscience's current stock value. Our valuation model uses many indicators to compare Amarantus Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amarantus Bioscience competition to find correlations between indicators driving Amarantus Bioscience's intrinsic value. More Info.Amarantus Bioscience Holdings is the top company in current valuation category among its peers. It also is number one stock in shares outstanding category among its peers creating about 10.36 of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amarantus Bioscience's earnings, one of the primary drivers of an investment's value.Amarantus Bioscience Systematic Risk
Amarantus Bioscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amarantus Bioscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Amarantus Bioscience correlated with the market. If Beta is less than 0 Amarantus Bioscience generally moves in the opposite direction as compared to the market. If Amarantus Bioscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amarantus Bioscience is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amarantus Bioscience is generally in the same direction as the market. If Beta > 1 Amarantus Bioscience moves generally in the same direction as, but more than the movement of the benchmark.
Amarantus Bioscience December 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Amarantus Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amarantus Bioscience Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amarantus Bioscience Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Amarantus Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amarantus Bioscience's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1662 | |||
| Maximum Drawdown | 990.0 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 100.0 |
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.